Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gerlach

Showing results (231-240 of 302) with videos related to

Pageof 31
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 4, 2012
Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during acute pulmonary thromboembolismOzelia Sousa-Santos, Evandro M Neto-Neves, Karina C Ferraz, et al.
Journal of Biotechnology|October 18, 2011
Expression of soluble and functional full-length human matrix metalloproteinase-2 in Escherichia coliAndrezza N Gonçalves, Cesar A Meschiari, William G Stetler-Stevenson, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 9, 2010
Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertensionDiogo M O Marçal, Elen Rizzi, Alisson Martins-Oliveira, et al.
International Journal of Medical Microbiology : IJMM|August 17, 2014
Facts, myths and hypotheses on the zoonotic nature of Mycobacterium avium subspecies paratuberculosisRaja Atreya, Michael Bülte, Gerald-F Gerlach, et al.
Infection and Immunity|April 2, 2008
Analysis of the Actinobacillus pleuropneumoniae ArcA regulon identifies fumarate reductase as a determinant of virulenceFalk F R Buettner, Ibrahim M Bendallah, Janine T Bosse, et al.
Critical Care Medicine|October 5, 2010
Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolismEvandro M Neto-Neves, Carlos A Dias-Junior, Elen Rizzi, et al.
Basic & Clinical Pharmacology & Toxicology|August 24, 2012
Recombinant human matrix metalloproteinase-2 impairs cardiovascular β-adrenergic responsesKarina C Ferraz, Ozélia Sousa-Santos, Evandro M Neto-Neves, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|February 21, 2012
Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertensionCarla S Ceron, Elen Rizzi, Danielle A Guimaraes, et al.
European Journal of Pharmacology|July 19, 2008
Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive ratsMarcio L L Martinez, Michele M Castro, Elen Rizzi, et al.
Clinical Chemistry and Laboratory Medicine|July 7, 2009
Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditionsRaquel F Gerlach, Cesar A Meschiari, Andrea M Marcaccini, et al.
Pageof 31

Showing results (231-240 of 302) with videos related to

Sort By:
Pageof 31
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 4, 2012
Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during acute pulmonary thromboembolismOzelia Sousa-Santos, Evandro M Neto-Neves, Karina C Ferraz, et al.
Journal of Biotechnology|October 18, 2011
Expression of soluble and functional full-length human matrix metalloproteinase-2 in Escherichia coliAndrezza N Gonçalves, Cesar A Meschiari, William G Stetler-Stevenson, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 9, 2010
Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertensionDiogo M O Marçal, Elen Rizzi, Alisson Martins-Oliveira, et al.
International Journal of Medical Microbiology : IJMM|August 17, 2014
Facts, myths and hypotheses on the zoonotic nature of Mycobacterium avium subspecies paratuberculosisRaja Atreya, Michael Bülte, Gerald-F Gerlach, et al.
Infection and Immunity|April 2, 2008
Analysis of the Actinobacillus pleuropneumoniae ArcA regulon identifies fumarate reductase as a determinant of virulenceFalk F R Buettner, Ibrahim M Bendallah, Janine T Bosse, et al.
Critical Care Medicine|October 5, 2010
Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolismEvandro M Neto-Neves, Carlos A Dias-Junior, Elen Rizzi, et al.
Basic & Clinical Pharmacology & Toxicology|August 24, 2012
Recombinant human matrix metalloproteinase-2 impairs cardiovascular β-adrenergic responsesKarina C Ferraz, Ozélia Sousa-Santos, Evandro M Neto-Neves, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|February 21, 2012
Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertensionCarla S Ceron, Elen Rizzi, Danielle A Guimaraes, et al.
European Journal of Pharmacology|July 19, 2008
Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive ratsMarcio L L Martinez, Michele M Castro, Elen Rizzi, et al.
Clinical Chemistry and Laboratory Medicine|July 7, 2009
Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditionsRaquel F Gerlach, Cesar A Meschiari, Andrea M Marcaccini, et al.
Pageof 31